These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32048692)

  • 1. The affinity of RSK for cylitol analogues of SL0101 is critically dependent on the B-ring C-4'-hydroxy.
    Li Y; Seber P; Wright EB; Yasmin S; Lannigan DA; O'Doherty GA
    Chem Commun (Camb); 2020 Mar; 56(20):3058-3060. PubMed ID: 32048692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Structure-Activity Relationship Study of 5a-Carbasugar Analogues of SL0101.
    Li M; Li Y; Mrozowski RM; Sandusky ZM; Shan M; Song X; Wu B; Zhang Q; Lannigan DA; O'Doherty GA
    ACS Med Chem Lett; 2015 Jan; 6(1):95-9. PubMed ID: 25589938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the affinity of SL0101 for RSK using structure-based design.
    Mrozowski RM; Vemula R; Wu B; Zhang Q; Schroeder BR; Hilinski MK; Clark DE; Hecht SM; O'Doherty GA; Lannigan DA
    ACS Med Chem Lett; 2012 Feb; 4(2):175-179. PubMed ID: 23519677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two widely used RSK inhibitors, BI-D1870 and SL0101, alter mTORC1 signaling in a RSK-independent manner.
    Roffé M; Lupinacci FC; Soares LC; Hajj GN; Martins VR
    Cell Signal; 2015 Aug; 27(8):1630-42. PubMed ID: 25889895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the activity of the RSK-specific inhibitor, SL0101.
    Smith JA; Maloney DJ; Hecht SM; Lannigan DA
    Bioorg Med Chem; 2007 Jul; 15(14):5018-34. PubMed ID: 17512736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation.
    Smith JA; Poteet-Smith CE; Xu Y; Errington TM; Hecht SM; Lannigan DA
    Cancer Res; 2005 Feb; 65(3):1027-34. PubMed ID: 15705904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regioselective Synthesis of a
    Li Y; Sandusky ZM; Vemula R; Zhang Q; Wu B; Fukuda S; Li M; Lannigan DA; O'Doherty GA
    Org Lett; 2020 Feb; 22(4):1448-1452. PubMed ID: 32009414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective Synthesis and Evaluation of C6″-Substituted 5a-Carbasugar Analogues of SL0101 as Inhibitors of RSK1/2.
    Li M; Li Y; Ludwik KA; Sandusky ZM; Lannigan DA; O'Doherty GA
    Org Lett; 2017 May; 19(9):2410-2413. PubMed ID: 28441024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of rhamnose substituents on the potency of SL0101, an inhibitor of the Ser/Thr kinase, RSK.
    Smith JA; Maloney DJ; Clark DE; Xu Y; Hecht SM; Lannigan DA
    Bioorg Med Chem; 2006 Sep; 14(17):6034-42. PubMed ID: 16723233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent off-target effects of RSK N-terminal and C-terminal kinase inhibitors in cardiac myocytes.
    Stathopoulou K; Schobesberger S; Bork NI; Sprenger JU; Perera RK; Sotoud H; Geertz B; David JP; Christ T; Nikolaev VO; Cuello F
    Cell Signal; 2019 Nov; 63():109362. PubMed ID: 31344438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14-3-3beta is a p90 ribosomal S6 kinase (RSK) isoform 1-binding protein that negatively regulates RSK kinase activity.
    Cavet ME; Lehoux S; Berk BC
    J Biol Chem; 2003 May; 278(20):18376-83. PubMed ID: 12618428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Clinical Implications of RSK1-3 in Human Breast Cancer.
    Zhao H; Martin TA; Davies EL; Ruge F; Yu H; Zhang Y; Teng XU; Jiang WG
    Anticancer Res; 2016 Mar; 36(3):1267-74. PubMed ID: 26977024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Biological Evaluation of 4'-Substituted Kaempfer-3-ols.
    Kim S; Li Y; Lin L; Sayasith PR; Tarr AT; Wright EB; Yasmin S; Lannigan DA; O'Doherty GA
    J Org Chem; 2020 Mar; 85(6):4279-4288. PubMed ID: 32056430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analogs of the RSK inhibitor SL0101: optimization of in vitro biological stability.
    Hilinski MK; Mrozowski RM; Clark DE; Lannigan DA
    Bioorg Med Chem Lett; 2012 May; 22(9):3244-7. PubMed ID: 22464132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation.
    Clark DE; Errington TM; Smith JA; Frierson HF; Weber MJ; Lannigan DA
    Cancer Res; 2005 Apr; 65(8):3108-16. PubMed ID: 15833840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bradykinin-stimulated protein synthesis by myocytes is dependent on the MAP kinase pathway and p70(S6K).
    Ritchie RH; Marsh JD; Schiebinger RJ
    Am J Physiol; 1999 Apr; 276(4):H1393-8. PubMed ID: 10199867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of regulatory events associated with membrane targeting of p90 ribosomal S6 kinase 1.
    Richards SA; Dreisbach VC; Murphy LO; Blenis J
    Mol Cell Biol; 2001 Nov; 21(21):7470-80. PubMed ID: 11585927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo synthesis and biological evaluation of C6″-substituted C4″-amide analogues of SL0101.
    Mrozowski RM; Sandusky ZM; Vemula R; Wu B; Zhang Q; Lannigan DA; O'Doherty GA
    Org Lett; 2014 Nov; 16(22):5996-9. PubMed ID: 25372628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intracellular calcium signal activates p70 but not p90 ribosomal S6 kinase in liver epithelial cells.
    Graves LM; He Y; Lambert J; Hunter D; Li X; Earp HS
    J Biol Chem; 1997 Jan; 272(3):1920-8. PubMed ID: 8999881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo.
    Smith JA; Poteet-Smith CE; Malarkey K; Sturgill TW
    J Biol Chem; 1999 Jan; 274(5):2893-8. PubMed ID: 9915826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.